Next Article in Journal
A Facile One-pot Synthesis of 1-Arylpyrazolo[3,4-d]Pyrimidin- 4-ones
Next Article in Special Issue
Antifungal Effect of (+)-Pinoresinol Isolated from Sambucus williamsii
Previous Article in Journal
MDL-28170 Has No Analgesic Effect on CCI Induced Neuropathic Pain in Mice
Previous Article in Special Issue
Arginine as a Synergistic Virucidal Agent
Molecules 2010, 15(5), 3048-3078; doi:10.3390/molecules15053048
Review

Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors

1
 and 2,*
Received: 2 March 2010; in revised form: 8 April 2010 / Accepted: 12 April 2010 / Published: 27 April 2010
(This article belongs to the Special Issue Anti-Infective Agents)
Download PDF [776 KB, uploaded 18 June 2014]
Abstract: In spite of significant progress in anti-HIV-1 therapy, current antiviral chemo-therapy still suffers from deleterious side effects and emerging drug resistance. Therefore, the development of novel antiviral drugs remains a crucial issue for the fight against AIDS. HIV-1 integrase is a key enzyme in the replication cycle of the retrovirus since it catalyzes the integration of the reverse transcribed viral DNA into the chromosomal DNA. Efforts to develop anti-integrase drugs started during the early nineties, culminating with the recent approval of Raltegravir. The discovery and the development of the styrylquinoline inhibitor class was an important step in the overall process. In this review we have described the key synthetic issues and the structure-activity relationship of this family of integrase inhibitors. Crystallographic and docking studies that shed light on their mechanism of action are also examined.
Keywords: AIDS; HIV-1; integrase; inhibitor; styrylquinoline AIDS; HIV-1; integrase; inhibitor; styrylquinoline
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Mouscadet, J.-F.; Desmaële, D. Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors. Molecules 2010, 15, 3048-3078.

AMA Style

Mouscadet J-F, Desmaële D. Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors. Molecules. 2010; 15(5):3048-3078.

Chicago/Turabian Style

Mouscadet, Jean-François; Desmaële, Didier. 2010. "Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors." Molecules 15, no. 5: 3048-3078.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert